AmirGoldkornMD
Oncology • Los Angeles, CAGenitourinary Oncology
Associate Professor, Medicine, USC School of Medicine
Dr. Goldkorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1441 Eastlake Ave
Los Angeles, CA 90089Phone+1 323-865-3105Fax+1 323-442-5953- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2002 - 2005
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1998 - 2001
David Geffen School of Medicine at UCLAClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2024
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III tria...Primo N Lara Jr, Edward Mayerson, Erik Gertz, Catherine Tangen, Amir Goldkorn, Marta van Loan, Maha Hussain, Shilpa Gupta, Jingsong Zhang, Mamta Parikh, Przemyslaw Twa...> ;Prostate Cancer and Prostatic Diseases. 2024 Feb 29
- 1 citationsAssociation of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.Lerner, S., McConkey, D., Tangen, C., Meeks, J., Flaig, T., Hua, X., Daneshmand, S., Alva, A., Lucia, M., Theodorescu, D., Goldkorn, A., Milowsky, M., Choi, W., Bangs,...> ;Clinical Cancer Research. 2024 Jan 17
- mA epitranscriptome analysis reveals differentially methylated transcripts that drive early chemoresistance in bladder cancer.Emmanuelle Hodara, Aubree Mades, Lisa Swartz, Maheen Iqbal, Tong Xu, Daniel Bsteh, Peggy J Farnham, Suhn K Rhie, Amir Goldkorn> ;NAR Cancer. 2023 Dec 1
- Join now to see all
Press Mentions
RareCyte Announces First Commercially Available ARv7/Synaptophysin CTC Assay for Blood-Based Characterization of Treatment Resistant Prostate CancerAugust 26th, 2020- New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast CancerJune 8th, 2020
Beating Back Prostate CancerOctober 25th, 2016- Join now to see all
Grant Support
- Targeting Cancer With Telomerase InterferenceNational Cancer Institute2007–2011
- Circulating Tumor Cell Capture &Analysis In A Multi-Center Prostate Cancer TrialNational Cancer Institute2009
Professional Memberships
- Member
Hospital Affiliations
Keck Hospital of USCLos Angeles, California
USC Norris Comprehensive Cancer CenterLos Angeles, California
Los Angeles General Medical CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
